UB Paderborn / Katalog / Suche / in CDI

Clinical Course of Patients With Hyponatremia and Decompensated Systolic Heart Failure and the Effect of Vasopressin Receptor Antagonism With Tolvaptan

Journal of cardiac failure, 2013-06, Vol.19 (6), p.390-397

2013

Volltextzugriff (PDF)

Human Hypertension Is Characterized by a Lack of Activation of the Antihypertensive Cardiac Hormones ANP and BNP

Journal of the American College of Cardiology, 2012-10, Vol.60 (16), p.1558-1565

2012

Volltextzugriff (PDF)

Innovative Therapeutics

JACC. Basic to translational science, 2016-12, Vol.1 (7), p.557-567

2016

Volltextzugriff (PDF)

Design, Synthesis, and Actions of a Novel Chimeric Natriuretic Peptide: CD-NP

Journal of the American College of Cardiology, 2008-07, Vol.52 (1), p.60-68

2008

Volltextzugriff (PDF)

A Genetic Variant of the Atrial Natriuretic Peptide Gene Is Associated With Cardiometabolic Protection in the General Community

Journal of the American College of Cardiology, 2011-08, Vol.58 (6), p.629-636

2011

Volltextzugriff (PDF)

The Prognostic Value of N-Terminal Pro–B-Type Natriuretic Peptide for Death and Cardiovascular Events in Healthy Normal and Stage A/B Heart Failure Subjects

Journal of the American College of Cardiology, 2010-05, Vol.55 (19), p.2140-2147

2010

Volltextzugriff (PDF)

Novel Protein Therapeutics for Systolic Heart Failure

Journal of the American College of Cardiology, 2012-12, Vol.60 (22), p.2305-2312

2012

Volltextzugriff (PDF)

Biology of the Natriuretic Peptides

The American journal of cardiology, 2008-02, Vol.101 (3), p.S3-S8

2008

Volltextzugriff (PDF)

Effect of Neurohormonal Blockade Drug Therapy on Outcomes and Left Ventricular Function and Structure After Left Ventricular Assist Device Implantation

The American journal of cardiology, 2016-06, Vol.117 (11), p.1765-1770

2016

Volltextzugriff (PDF)

Impaired Natriuretic and Renal Endocrine Response to Acute Volume Expansion in Pre-Clinical Systolic and Diastolic Dysfunction

Journal of the American College of Cardiology, 2011-11, Vol.58 (20), p.2095-2103

2011

Volltextzugriff (PDF)

Elevated Plasma PCSK9 Level Is Equally Detrimental for Patients With Nonfamilial Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia, Irrespective of Low-Density Lipoprotein Receptor Defects

Journal of the American College of Cardiology, 2014-06, Vol.63 (22), p.2365-2373

2014

Volltextzugriff (PDF)

Alternate Circulating Pro-B-Type Natriuretic Peptide and B-Type Natriuretic Peptide Forms in the General Population

Journal of the American College of Cardiology, 2007-03, Vol.49 (11), p.1193-1202

2007

Volltextzugriff (PDF)

Predictive Utility of Atrial, N-Terminal Pro-Atrial, and N-Terminal Pro-B-Type Natriuretic Peptides for Mortality and Cardiovascular Events in the General Community: A 9-Year Follow-up Study

Mayo Clinic proceedings, 2011-12, Vol.86 (12), p.1154-1160

2011

Volltextzugriff (PDF)

NT-proBNP

Journal of the American College of Cardiology, 2016-12, Vol.68 (22), p.2437-2439

2016

Volltextzugriff (PDF)

A Human Atrial Natriuretic Peptide Gene Mutation Reveals a Novel Peptide With Enhanced Blood Pressure-Lowering, Renal-Enhancing, and Aldosterone-Suppressing Actions

Journal of the American College of Cardiology, 2009-09, Vol.54 (11), p.1024-1032

2009

Volltextzugriff (PDF)

Effects of tolvaptan on physician-assessed symptoms and signs in patients hospitalized with acute heart failure syndromes: Analysis from the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) Trials

The American heart journal, 2011-06, Vol.161 (6), p.1067-1072

2011

Volltextzugriff (PDF)

Sustained Blood Pressure–Lowering Actions of Subcutaneous B-Type Natriuretic Peptide (Nesiritide) in a Patient With Uncontrolled Hypertension

Mayo Clinic proceedings, 2012-04, Vol.87 (4), p.413-415

2012

Volltextzugriff (PDF)

Cardiac Resynchronization Therapy Improves Renal Function in Human Heart Failure With Reduced Glomerular Filtration Rate

Journal of cardiac failure, 2008-09, Vol.14 (7), p.539-546

2008

Volltextzugriff (PDF)

Chronic Peptide Therapy With B-Type Natriuretic Peptide in Patients With Pre-Clinical Diastolic Dysfunction (Stage B Heart Failure)

JACC. Heart failure, 2016-07, Vol.4 (7), p.539-547

2016

Volltextzugriff (PDF)

Protein Therapeutics for Cardiovascular Disease

Journal of the American College of Cardiology, 2012-12, Vol.60 (24), p.2558-2560

2012

Volltextzugriff (PDF)

National Heart, Lung, and Blood Institute Working Group on Emergency Department Management of Acute Heart Failure

Journal of the American College of Cardiology, 2010-07, Vol.56 (5), p.343-351

2010

Volltextzugriff (PDF)

Rationale and Design of a Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy of B-Type Natriuretic Peptide for the Preservation of Left Ventricular Function After Anterior Myocardial Infarction

Journal of cardiac failure, 2013-08, Vol.19 (8), p.533-539

2013

Volltextzugriff (PDF)

The Effect of the Brain-Type Natriuretic Peptide Single-Nucleotide Polymorphism rs198389 on Test Characteristics of Common Assays

Mayo Clinic proceedings, 2011-03, Vol.86 (3), p.210-218

2011

Volltextzugriff (PDF)

Secretion of Prohormone of B-Type Natriuretic Peptide, proBNP1-108 , Is Increased in Heart Failure

JACC. Heart failure, 2013-06, Vol.1 (3), p.207-212

2013

Volltextzugriff (PDF)

Natriuretic Peptides in the Diagnosis and Management of Chronic Heart Failure

Heart failure clinics, 2009-10, Vol.5 (4), p.501-514

2009

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Clinical Course of Patients With Hyponatremia and Decompensated Systolic Heart Failure and the Effect of Vasopressin Receptor Antagonism With Tolvaptan

Human Hypertension Is Characterized by a Lack of Activation of the Antihypertensive Cardiac Hormones ANP and BNP

Innovative Therapeutics

Design, Synthesis, and Actions of a Novel Chimeric Natriuretic Peptide: CD-NP

A Genetic Variant of the Atrial Natriuretic Peptide Gene Is Associated With Cardiometabolic Protection in the General Community

The Prognostic Value of N-Terminal Pro–B-Type Natriuretic Peptide for Death and Cardiovascular Events in Healthy Normal and Stage A/B Heart Failure Subjects

Novel Protein Therapeutics for Systolic Heart Failure

Biology of the Natriuretic Peptides

Effect of Neurohormonal Blockade Drug Therapy on Outcomes and Left Ventricular Function and Structure After Left Ventricular Assist Device Implantation

Impaired Natriuretic and Renal Endocrine Response to Acute Volume Expansion in Pre-Clinical Systolic and Diastolic Dysfunction

Elevated Plasma PCSK9 Level Is Equally Detrimental for Patients With Nonfamilial Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia, Irrespective of Low-Density Lipoprotein Receptor Defects

Alternate Circulating Pro-B-Type Natriuretic Peptide and B-Type Natriuretic Peptide Forms in the General Population

Predictive Utility of Atrial, N-Terminal Pro-Atrial, and N-Terminal Pro-B-Type Natriuretic Peptides for Mortality and Cardiovascular Events in the General Community: A 9-Year Follow-up Study

NT-proBNP

A Human Atrial Natriuretic Peptide Gene Mutation Reveals a Novel Peptide With Enhanced Blood Pressure-Lowering, Renal-Enhancing, and Aldosterone-Suppressing Actions

Effects of tolvaptan on physician-assessed symptoms and signs in patients hospitalized with acute heart failure syndromes: Analysis from the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) Trials

Sustained Blood Pressure–Lowering Actions of Subcutaneous B-Type Natriuretic Peptide (Nesiritide) in a Patient With Uncontrolled Hypertension

Cardiac Resynchronization Therapy Improves Renal Function in Human Heart Failure With Reduced Glomerular Filtration Rate

Chronic Peptide Therapy With B-Type Natriuretic Peptide in Patients With Pre-Clinical Diastolic Dysfunction (Stage B Heart Failure)

Protein Therapeutics for Cardiovascular Disease

National Heart, Lung, and Blood Institute Working Group on Emergency Department Management of Acute Heart Failure

Rationale and Design of a Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy of B-Type Natriuretic Peptide for the Preservation of Left Ventricular Function After Anterior Myocardial Infarction

The Effect of the Brain-Type Natriuretic Peptide Single-Nucleotide Polymorphism rs198389 on Test Characteristics of Common Assays

Secretion of Prohormone of B-Type Natriuretic Peptide, proBNP1-108 , Is Increased in Heart Failure

Natriuretic Peptides in the Diagnosis and Management of Chronic Heart Failure

Suchergebnisse filtern